Folate receptor-targeted drugs for cancer and inflammatory diseases - Preface

[1] Adams GP, 2001, CANCER RES, V61, P4750

[2] ANTONY AC, 1992, BLOOD, V79, P2807

[3] Conjugation of folate via gelonin carbohydrate residues retains ribosomal-inactivating properties of the toxin and permits targeting to folate receptor positive cells [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (30) : 27930 - 27935

[4] Single-chain Fv/folate conjugates mediate efficient lysis of folate-receptor-positive tumor cells [J]. BIOCONJUGATE CHEMISTRY, 1997, 8 (03) : 338 - 346

[5] Targeting folate receptor with folate linked to extremities of poly(ethylene glycol)-grafted liposomes: In vitro studies [J]. BIOCONJUGATE CHEMISTRY, 1999, 10 (02) : 289 - 298

[6] Goren D, 2000, CLIN CANCER RES, V6, P1949

[7] Gosselin Michael A, 2002, Biotechnol Annu Rev, V8, P103, DOI 10.1016/S1387-2656(02)08006-7

[8] Understanding endocytic pathways and intracellular trafficking: a prerequisite for effective design of advanced drug delivery systems [J]. ADVANCED DRUG DELIVERY REVIEWS, 2003, 55 (11) : 1353 - 1357

[9] Specific targeting of folate-dendrimer MRI contrast agents to the high affinity fo late receptor expressed in ovarian tumor xenografts [J]. MAGNETIC RESONANCE MATERIALS IN PHYSICS BIOLOGY AND MEDICINE, 2001, 12 (2-3) : 104 - 113

[10] SELECTIVE TARGETING OF MALIGNANT-CELLS WITH CYTOTOXIN-FOLATE CONJUGATES [J]. JOURNAL OF DRUG TARGETING, 1994, 2 (02) : 101 - 112

[1] Adams GP, 2001, CANCER RES, V61, P4750

[2] ANTONY AC, 1992, BLOOD, V79, P2807

[3] Conjugation of folate via gelonin carbohydrate residues retains ribosomal-inactivating properties of the toxin and permits targeting to folate receptor positive cells [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (30) : 27930 - 27935

[4] Single-chain Fv/folate conjugates mediate efficient lysis of folate-receptor-positive tumor cells [J]. BIOCONJUGATE CHEMISTRY, 1997, 8 (03) : 338 - 346

[5] Targeting folate receptor with folate linked to extremities of poly(ethylene glycol)-grafted liposomes: In vitro studies [J]. BIOCONJUGATE CHEMISTRY, 1999, 10 (02) : 289 - 298

[6] Goren D, 2000, CLIN CANCER RES, V6, P1949

[7] Gosselin Michael A, 2002, Biotechnol Annu Rev, V8, P103, DOI 10.1016/S1387-2656(02)08006-7

[8] Understanding endocytic pathways and intracellular trafficking: a prerequisite for effective design of advanced drug delivery systems [J]. ADVANCED DRUG DELIVERY REVIEWS, 2003, 55 (11) : 1353 - 1357

[9] Specific targeting of folate-dendrimer MRI contrast agents to the high affinity fo late receptor expressed in ovarian tumor xenografts [J]. MAGNETIC RESONANCE MATERIALS IN PHYSICS BIOLOGY AND MEDICINE, 2001, 12 (2-3) : 104 - 113

[10] SELECTIVE TARGETING OF MALIGNANT-CELLS WITH CYTOTOXIN-FOLATE CONJUGATES [J]. JOURNAL OF DRUG TARGETING, 1994, 2 (02) : 101 - 112